Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Appili Therapeutics Inc T.APLI

Alternate Symbol(s):  APLIF

Healthcare Biotechnology
Appili Therapeutics Inc. is a Canada-based biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. The Company is advancing a diverse range of anti-infectives, including ready-made suspension of metronidazole for the treatment of antimicrobial infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical... see more

Bullboard (TSX:APLI)

View:
Prev 1 2 3 4 5 6 Next
Post by Mohamedon Sep 16, 2021 12:24pm

Great news!

Glenmark Pharmaceuticals concludes PMS study on Favipiravir (FabiFlu) in 1000+ COVID-19 patients; results show no new safety signals or concerns (INR 533.65, +2.10)   https://www ...more  
185
Post by mingzhuon Sep 15, 2021 12:27pm

research study

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis Conclusions Favipiravir induces viral clearance by 7 days and contributes to clinical improvement within ...more  
177
Post by mingzhuon Sep 13, 2021 1:44pm

target $3.25

https://vnexplorer.net/aplif-awaiting-data-readout-for-phase-3-preseco-trial-in-covid-19-ez2021254920.html
147
Comment by mingzhuon Sep 08, 2021 11:46am

RE:it is moving before the result of covid 19 drug by the end

target $2.75 https://leedejonesgable.com/wp-content/uploads/APLI_2021_06_25.pdf
119
Discussion
Post by TheBearInTheWoodson Aug 13, 2021 11:08am

Phase II Clinical Data going for third party review

Phase II Clinical Data going for third party review "Arch Biopartners Inc. has provided an update that the analysis of the results of the phase II trial of its lead drug LSALT peptide (metablok) ...more  
172
Post by Joeking123on Jul 29, 2021 12:09pm

Alzheimergem Spamming all boards

BEWARE!!!! Red flag when spamming starts
75
Post by gr8stockson Jul 14, 2021 1:19pm

Appili Therapeutics: a David taking on the COVID-19 Goliath

BNN published an article this morning about Appili Therapeutics. The article atalks about the company's goal to fight against infectious diseases with a mission to find solutions against life ...more  
245
Post by TheBearInTheWoodson Jul 06, 2021 10:15pm

Appili Therapeutics has $16.1M of cash at March 31

APPILI THERAPEUTICS REPORTS FISCAL YEAR 2021 FINANCIAL AND OPERATIONAL RESULTS AND PROVIDES UPDATE ON STRATEGY FOR FISCAL 2022 Appili Therapeutics Inc. has released its financial and operational ...more  
239
Post by mercedesmanon Apr 29, 2021 5:32pm

"two weeks away from published results"...

....on their favipiravir out patient trial ....  856 participants. If positive...immediate EU FDA Approval.  Could be explosive to the share price. This is the first in front of the FDA on ...more  
408
Post by bhikku2on Apr 22, 2021 5:00pm

Today's presentation/interview

With Adelaide Capital https://www.youtube.com/watch?v=PVCnf20xPuU
240
Post by TheBearInTheWoodson Mar 08, 2021 9:46pm

Where’s the floor

This company has real potential and yet seems to be sitting it out 
169
Post by pinkpanther2021on Feb 23, 2021 10:49am

any idea why the share price has been going down like this?

The selling since mid-February has been relentless with apparently no reason. Zacks research report sums up why this company can and should be a winner but obviously something is going on behind the ...more  
308
Post by Pickheroon Feb 10, 2021 1:56pm

CHEAPEST Covid 19 Phase 3 Gem with IMMINENT readout

Company expect to submit 2 NDA´s for US Market approval including the covid 19 treatment  during the year . Covid 19 drug is currently under review in Canada and approval could hit the wire ...more  
358
Prev 1 2 3 4 5 6 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities